March 28, 2023

ATA Action's Letter to the DEA Re: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation

ATA Action Letter

ATA Action submitted comments regarding the Drug Enforcement Administration (DEA)’s proposed rules regarding telemedicine prescribing of controlled substances when the practitioner and the patient have not had a prior in-person medical evaluation.